Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT.

Chronic Disease Consensus Endarterectomy / standards Humans Hypertension, Pulmonary / diagnosis Pulmonary Embolism / complications Thrombolytic Therapy / standards
CTEPH balloon pulmonary angioplasty guidelines pulmonary emboli pulmonary hypertension pulmonary thromboendarterectomy

Journal

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
ISSN: 1557-3117
Titre abrégé: J Heart Lung Transplant
Pays: United States
ID NLM: 9102703

Informations de publication

Date de publication:
11 2021
Historique:
received: 17 07 2021
accepted: 22 07 2021
pubmed: 24 8 2021
medline: 4 3 2022
entrez: 23 8 2021
Statut: ppublish

Résumé

ISHLT members have recognized the importance of a consensus statement on the evaluation and management of patients with chronic thromboembolic pulmonary hypertension. The creation of this document required multiple steps, including the engagement of the ISHLT councils, approval by the Standards and Guidelines Committee, identification and selection of experts in the field, and the development of 6 working groups. Each working group provided a separate section based on an extensive literature search. These sections were then coalesced into a single document that was circulated to all members of the working groups. Key points were summarized at the end of each section. Due to the limited number of comparative trials in this field, the document was written as a literature review with expert opinion rather than based on level of evidence.

Identifiants

DOI: 10.1016/j.healun.2021.07.020 PMID: 34420851
pubmed: 34420851
pii: S1053-2498(21)02440-2
doi: 10.1016/j.healun.2021.07.020
pii:
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

1301-1326

Informations de copyright

Copyright © 2021 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Auteurs

Marc de Perrot (M)

Division of Thoracic Surgery, Toronto General Hospital, Toronto, Ontario, Canada. Electronic address: marc.deperrot@uhn.ca.

Deepa Gopalan (D)

Department of Radiology, Imperial College Healthcare NHS Trust, London & Cambridge University Hospital, Cambridge, UK.

David Jenkins (D)

National Pulmonary Endarterectomy Service, Department of Cardiothoracic Surgery, Papworth Hospital, Cambridge, UK.

Irene M Lang (IM)

Department of Cardiology, Pulmonary Hypertension Unit, Medical University of Vienna, Vienna, Austria.

Elie Fadel (E)

Department of Thoracic and Vascular Surgery and Heart Lung Transplantation, Marie-Lannelongue Hospital, Paris Saclay University, Le Plessis-Robinson, France.

Marion Delcroix (M)

Clinical Department of Respiratory Diseases, Pulmonary Hypertension Centre, UZ Leuven, Leuven, Belgium; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism (CHROMETA), KU, Leuven, Belgium.

Raymond Benza (R)

Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio.

Gustavo A Heresi (GA)

Department of Pulmonary and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.

Manreet Kanwar (M)

Cardiovascular Institute, Allegheny Health Network, Pittsburgh, Pennsylvania.

John T Granton (JT)

Division of Respirology, University Health Network, Toronto, Ontario, Canada.

Micheal McInnis (M)

Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada.

Frederikus A Klok (FA)

Department of Medicine, Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.

Kim M Kerr (KM)

University of California San Diego Medical Health, Division of Pulmonary Critical Care and Sleep Medicine, San Diego, California.

Joanna Pepke-Zaba (J)

Pulmonary Vascular Disease Unit, Royal Papworth Hospital NHS foundation Trust, Cambridge, Cambridgeshire, UK.

Mark Toshner (M)

Pulmonary Vascular Disease Unit, Royal Papworth Hospital NHS foundation Trust, Cambridge, Cambridgeshire, UK; Heart Lung Research Institute, University of Cambridge, Cambridge, UK.

Anastasia Bykova (A)

Division of Thoracic Surgery, Toronto General Hospital, Toronto, Ontario, Canada.

Andrea M D' Armini (AM)

Unit of Cardiac Surgery, Intrathoracic-Trasplantation and Pulmonary Hypertension, University of Pavia, Foundation I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.

Ivan M Robbins (IM)

Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Michael Madani (M)

Department of Cardiovascular and Thoracic Surgery, University of California San Diego, La Jolla, California.

David McGiffin (D)

Department of Cardiothoracic Surgery, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.

Christoph B Wiedenroth (CB)

Department of Thoracic Surgery, Campus Kerckhoff of the University of Giessen, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.

Sebastian Mafeld (S)

Division of Vascular and Interventional Radiology, Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada.

Isabelle Opitz (I)

Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.

Olaf Mercier (O)

Department of Thoracic and Vascular Surgery and Heart Lung Transplantation, Marie-Lannelongue Hospital, Paris Saclay University, Le Plessis-Robinson, France.

Patricia A Uber (PA)

Pauley Heart Center, Virginia Commonwealth University Health System, Richmond, Virginia.

Robert P Frantz (RP)

Department of Cardiovascular Disease, Mayo Clinic College of Medicine, Rochester, Minnesota.

William R Auger (WR)

Pulmonary Hypertension and CTEPH Research Program, Temple Heart and Vascular Institute, Temple University, Lewis Katz School of Medicine, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie chronique › Evaluation and management of patients with...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › Evaluation and management of patients with...
questionsmedicales.fr › Procédures de chirurgie opératoire › Procédures de chirurgie cardiovasculaire › Procédures de chirurgie vasculaire › Endartériectomie › Evaluation and management of patients with...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Evaluation and management of patients with...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Hypertension artérielle › Hypertension pulmonaire › Evaluation and management of patients with...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Embolie et thrombose › Embolie › Embolie pulmonaire › Evaluation and management of patients with...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Traitement thrombolytique › Evaluation and management of patients with...